{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:24:47Z","timestamp":1790807087452,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:00Z","timestamp":1597795200000},"content-version":"vor","delay-in-days":384,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK080043"],"award-info":[{"award-number":["R01DK080043"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["Grant 7-12-CT-46"],"award-info":[{"award-number":["Grant 7-12-CT-46"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jlr.org"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1194\/jlr.p090647","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T15:09:06Z","timestamp":1560611346000},"page":"1432-1439","update-policy":"https:\/\/doi.org\/10.1194\/jlr.f110.005975","source":"Crossref","is-referenced-by-count":31,"title":["Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D"],"prefix":"10.1016","volume":"60","author":[{"given":"Arpita","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionut","family":"Bebu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Stoner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria F.","family":"Lopes-Virella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Timothy","family":"Garvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Alaupovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.P090647_bib1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00125-003-1116-6","article-title":"Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes","volume":"46","author":"Laing","year":"2003","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.P090647_bib2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","article-title":"High risk of cardiovascular disease in patients with type 1 diabetes in the UK: a cohort study using the general practice research database","volume":"29","author":"Soedamah-Muthu","year":"2006","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.P090647_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12933-018-0726-8","article-title":"Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA)","volume":"17","author":"Pease","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"Suppl. 2","key":"10.1194\/jlr.P090647_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2337\/diab.41.2.S18","article-title":"Identification of apoB-containing lipoprotein families in NIDDM","volume":"41","author":"Alaupovic","year":"1992","journal-title":"Diabetes."},{"key":"10.1194\/jlr.P090647_bib5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1194\/jlr.P080143","article-title":"Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D","volume":"59","author":"Basu","year":"2018","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P090647_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.metabol.2004.08.010","article-title":"ApoC-III bound to apoB-containing lipoproteins increase with insulin resistance in Cherokee Indian youth","volume":"54","author":"Blackett","year":"2005","journal-title":"Metabolism."},{"key":"10.1194\/jlr.P090647_bib7","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2337\/db11-1272","article-title":"Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes","volume":"61","author":"Sasongko","year":"2012","journal-title":"Diabetes."},{"key":"10.1194\/jlr.P090647_bib8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1373\/clinchem.2009.136994","article-title":"Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population","volume":"56","author":"Ley","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P090647_bib9","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1161\/CIRCULATIONAHA.107.713438","article-title":"Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment","volume":"117","author":"Kastelein","year":"2008","journal-title":"Circulation."},{"key":"10.1194\/jlr.P090647_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacc.2008.04.052","volume":"52","author":"Ballantyne","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.P090647_bib11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/CS20070308","article-title":"Apolipoprotein C-III: understanding an emerging cardiovascular risk factor","volume":"114","author":"Ooi","year":"2008","journal-title":"Clin. Sci. (Lond.)."},{"key":"10.1194\/jlr.P090647_bib12","doi-asserted-by":"crossref","first-page":"e1002146","DOI":"10.1371\/journal.pmed.1002146","article-title":"Circulating apolipoprotein E concentration and cardiovascular disease risk: meta-analysis of results from three studies","volume":"13","author":"Sofat","year":"2016","journal-title":"PLoS Med."},{"key":"10.1194\/jlr.P090647_bib13","doi-asserted-by":"crossref","first-page":"10771","DOI":"10.1016\/S0021-9258(18)87014-4","article-title":"Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein","volume":"265","author":"Kowal","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.P090647_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11883-003-0036-8","article-title":"The concept of apolipoprotein-defined lipoprotein families and its clinical significance","volume":"5","author":"Alaupovic","year":"2003","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1194\/jlr.P090647_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0076-6879(96)63004-3","article-title":"Significance of apolipoproteins for structure, function, and classification of plasma lipoproteins","volume":"263","author":"Alaupovic","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1194\/jlr.P090647_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.81.2.470","article-title":"Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors","volume":"81","author":"Blankenhorn","year":"1990","journal-title":"Circulation."},{"key":"10.1194\/jlr.P090647_bib17","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/01.ATV.14.12.1906","article-title":"Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS)","volume":"14","author":"Alaupovic","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1194\/jlr.P090647_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.P090647_bib19","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/db14-0930","article-title":"Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT\/EDIC","volume":"64","author":"Lachin","year":"2015","journal-title":"Diabetes."},{"key":"10.1194\/jlr.P090647_bib20","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa022314","article-title":"Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus","volume":"348","author":"Nathan","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.P090647_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/db10-0296","article-title":"Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"60","author":"Polak","year":"2011","journal-title":"Diabetes."},{"key":"10.1194\/jlr.P090647_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.atherosclerosis.2015.10.106","article-title":"Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes","volume":"244","author":"Basu","year":"2016","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P090647_bib23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1464-5491.2006.01905.x","article-title":"Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT\/EDIC cohort: associations with carotid intima-media thickness","volume":"23","author":"Lyons","year":"2006","journal-title":"Diabet. Med."},{"key":"10.1194\/jlr.P090647_bib24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/dc11-2040","article-title":"High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes","volume":"35","author":"Lopes-Virella","year":"2012","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.P090647_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2013.09.027","article-title":"Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes","volume":"231","author":"Hunt","year":"2013","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P090647_bib26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.atherosclerosis.2010.11.012","article-title":"Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes","volume":"214","author":"Lopes-Virella","year":"2011","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P090647_bib27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2337\/diacare.15.7.886","article-title":"Lipid and lipoprotein levels in patients with IDDM diabetes control and complication. Trial experience","volume":"15","year":"1992","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.P090647_bib28","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-2275(20)42943-8","article-title":"Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions","volume":"11","author":"Burstein","year":"1970","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P090647_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1139\/o81-079","article-title":"David Rubinstein Memorial Lecture: the biochemical and clinical significance of the interrelationship between very low density and high density lipoproteins","volume":"59","author":"Alaupovic","year":"1981","journal-title":"Can. J. Biochem."},{"key":"10.1194\/jlr.P090647_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ajcn\/85.2.369","article-title":"Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes","volume":"85","author":"Hilpert","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.P090647_bib31","first-page":"573","article-title":"Differential turbidimetric assay for subpopulations of lipoproteins containing apolipoprotein A-I","volume":"26","author":"M\u00e4rz","year":"1988","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1194\/jlr.P090647_bib32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ki.1987.219","article-title":"Serum apolipoprotein profile of patients with chronic renal failure","volume":"32","author":"Attman","year":"1987","journal-title":"Kidney Int."},{"key":"10.1194\/jlr.P090647_bib33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/dc13-2116","article-title":"Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Lachin","year":"2014","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.P090647_bib34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up","volume":"39","year":"2016","journal-title":"Diabetes Care."},{"key":"10.1194\/jlr.P090647_bib35","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":"Risk factors for cardiovascular disease in type 1 diabetes","volume":"65","year":"2016","journal-title":"Diabetes."},{"key":"10.1194\/jlr.P090647_bib36","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1007\/s00125-017-4374-4","article-title":"The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT\/EDIC study","volume":"60","author":"Bebu","year":"2017","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.P090647_bib37","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1016\/S0021-9258(18)55263-7","article-title":"Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway","volume":"266","author":"Sehayek","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1194\/jlr.P090647_bib38","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/CIRCULATIONAHA.109.875807","article-title":"Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype","volume":"121","author":"Zheng","year":"2010","journal-title":"Circulation."},{"key":"10.1194\/jlr.P090647_bib39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1194\/jlr.M900346-JLR200","article-title":"Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions","volume":"51","author":"Sundaram","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P090647_bib40","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacl.2015.05.002","article-title":"The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis","volume":"9","author":"Wyler von Ballmoos","year":"2015","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.P090647_bib41","doi-asserted-by":"crossref","first-page":"e007824","DOI":"10.1161\/JAHA.117.007824","article-title":"High-density lipoprotein subspecies defined by apolipoprotein C-III and subclinical atherosclerosis measures: MESA (the Multi-Ethnic Study of Atherosclerosis)","volume":"7","author":"Aroner","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1194\/jlr.P090647_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.atherosclerosis.2017.12.029","article-title":"High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals","volume":"269","author":"Yamamoto","year":"2018","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P090647_bib43","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/CIRCULATIONAHA.117.031276","article-title":"High-density lipoprotein subspecies defined by presence of apolipoprotein C-III and incident coronary heart disease in four cohorts","volume":"137","author":"Jensen","year":"2018","journal-title":"Circulation."},{"key":"10.1194\/jlr.P090647_bib44","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.STR.0000140629.65145.3c","article-title":"Apolipoprotein B\/apolipoprotein A-I in relation to the metabolic syndrome and change in carotid artery intima-media thickness during 3 years in middle-aged men","volume":"35","author":"Wallenfeldt","year":"2004","journal-title":"Stroke."},{"key":"10.1194\/jlr.P090647_bib45","doi-asserted-by":"crossref","first-page":"e54628","DOI":"10.1371\/journal.pone.0054628","article-title":"Both serum apolipoprotein B and the apolipoprotein B\/apolipoprotein A-I ratio are associated with carotid intima-media thickness","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One."},{"key":"10.1194\/jlr.P090647_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/01.ATV.17.4.715","article-title":"The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial","volume":"17","author":"Alaupovic","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P090647_bib47","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s001250051366","article-title":"Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes","volume":"43","author":"Gervaise","year":"2000","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.P090647_bib48","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/acr.21646","article-title":"Apolipoprotein B-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis","volume":"64","author":"Knowlton","year":"2012","journal-title":"Arthritis Care Res. (Hoboken)."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520322379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520322379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.P090647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T16:13:43Z","timestamp":1721405623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520322379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0022227520322379"],"URL":"https:\/\/doi.org\/10.1194\/jlr.p090647","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}